{"product_id":"next-generation-sequencing-ngs-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eNext-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview 2023-2028:\u003c\/p\u003e\n\n\u003cp\u003eThe global next-generation sequencing (NGS) market size reached US$ 17.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 48.9 Billion by 2028, exhibiting a growth rate (CAGR) of 18.5% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eNext-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section of the deoxyribonucleic acid (DNA). It involves various procedures, such as sequencing by synthesis (SBS) and ion semiconductor, single-molecule real-time (SMRT), and nanopore sequencing. It is a cost-effective solution that assists medical professionals in achieving precise results with high accuracy and speed. It also facilitates research in the fields of clinical diagnostics, personalized and genetic medicines, and agriculture and animal studies. At present, it is utilized in pharmacogenomics to escalate the drug delivery process.\u003c\/p\u003e\n\n\u003cp\u003eNext-Generation Sequencing (NGS) Market Trends:\u003cbr\u003e\nThe growing global geriatric population and the rising prevalence of various chronic medical disorders, such as cancer, cardiovascular, and neurological disorders, represent one of the key factors positively influencing the market. It can also be attributed to the growing use of genetic maps for guiding scientists to analyze the genes that are responsible for medical conditions. In addition, the widespread adoption of liquid biopsies in cancer diagnostics and the increasing utilization of NGS technologies to introduce non-invasive cancer biomarkers for real-time cancer monitoring and detection are creating a positive market outlook. In line with this, continuous technological innovations in sequencers, such as the integration of cloud-computing systems for enhanced data security and management, are strengthening the market growth. Apart from this, continuous financing by governments of various countries to improve healthcare infrastructure is providing a thrust to the market growth. Furthermore, increasing investments by leading players in research and development (R\u0026amp;D) activities for molecular biology, technical engineering, and sequencing chemistry is offering a favorable market outlook.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each segment of the global next-generation sequencing (NGS) market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Sequencing Type:\u003c\/p\u003e\n\n\u003cp\u003eWhole Genome Sequencing\u003cbr\u003e\nTargeted Resequencing\u003cbr\u003e\nWhole Exome Sequencing\u003cbr\u003e\nRNA Sequencing\u003cbr\u003e\nCHIP Sequencing\u003cbr\u003e\nDe Novo Sequencing\u003cbr\u003e\nMethyl Sequencing\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nTargeted resequencing represents the largest market segment due to the presence of numerous companies in the NGS market offering targeted resequencing services.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product Type:\u003c\/p\u003e\n\n\u003cp\u003eInstruments\u003cbr\u003e\nReagents and Consumables\u003cbr\u003e\nSoftware and Services\u003cbr\u003e\n \u003cbr\u003e\nReagents and consumables represent the most commonly used product type that assists in sample preparation, DNA isolation, sample cleanup, target enrichment, and quality assurance.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Technology:\u003c\/p\u003e\n\n\u003cp\u003eSequencing by Synthesis\u003cbr\u003e\nIon Semiconductor Sequencing\u003cbr\u003e\nSingle-Molecule Real-Time Sequencing\u003cbr\u003e\nNanopore Sequencing\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nSequencing by synthesis finds extensive applications on account of its high accuracy in performing DNA sequencing and its growing incorporation in NGS instrumentation. In addition, it offers the highest yield of error-free throughput results.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eBiomarker and Cancer\u003cbr\u003e\nDrug Discovery and Personalized Medicine\u003cbr\u003e\nGenetic Screening\u003cbr\u003e\nDiagnostics\u003cbr\u003e\nAgriculture and Animal Research\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBiomarker and cancer currently dominate the market due to the rising prevalence of cancer and increasing awareness among individuals about the benefits of early diagnosis and treatment.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eAcademic Institutes \u0026amp; Research Centers\u003cbr\u003e\nHospitals \u0026amp; Clinics\u003cbr\u003e\nPharmaceutical \u0026amp; Biotechnology Companies\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nAcademic institutes and research centers account for the majority of the market share due to the increasing application of NGS solutions in research projects.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nNorth America exhibits a clear dominance in the market due to the availability of a technologically advanced healthcare research framework in the region, coupled with the presence of multiple clinical laboratories that employ NGS to provide genetic testing services.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report\u003c\/p\u003e\n\n\u003cp\u003e1. What was the size of the global next-generation sequencing (NGS) market in 2022?\u003cbr\u003e\n2. What is the expected growth rate of the global next-generation sequencing (NGS) market during 2023-2028?\u003cbr\u003e\n3. What are the key factors driving the global next-generation sequencing (NGS) market?\u003cbr\u003e\n4. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?\u003cbr\u003e\n5. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?\u003cbr\u003e\n6. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?\u003cbr\u003e\n7. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?\u003cbr\u003e\n8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?\u003cbr\u003e\n9. What is the breakup of the global next-generation sequencing (NGS) market based on the end- user?\u003cbr\u003e\n10. What are the key regions in the global next-generation sequencing (NGS) market?\u003cbr\u003e\n11. Who are the key players\/companies in the global next-generation sequencing (NGS) market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 141 Pages \/ MCW16232947","offer_id":47648489177394,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/next-generation-sequencing-ngs-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}